CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RHHBY's Gazyva Gets FDA Priority Review for Label Expansion

RegulatoryGazyvaPositive
AI Analysis

Summary

Roche's Gazyva has received FDA Priority Review status for a label expansion indication. This regulatory milestone accelerates the review timeline for the expanded use of the drug.

Outcome Details

Priority Review granted for label expansion

Importance:6/10
Sentiment:
0.60
FDAPriority ReviewLabel ExpansionRegulatory
Related Companies

Read the original article

Published by yahoo_finance on July 15, 2026 4:07 PM

Read Original